# Cold Contact Urticaria Treatment With Rilonacept

> **NCT02171416** · PHASE2 · COMPLETED · sponsor: **Charite University, Berlin, Germany** · enrollment: 20 (actual)

## Conditions studied

- Cold Contact Urticaria

## Interventions

- **DRUG:** Rilonacept
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02171416
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2018-02-28
- **Final completion:** 2018-05
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2018-07-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02171416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02171416, "Cold Contact Urticaria Treatment With Rilonacept". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02171416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*